Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06143306 · ClinicalTrials.gov registry record · Phase 4
Addition of a Pectoserratus Block to Interscalene Block in Patients Undergoing Total Shoulder Replacement
A Phase 4 study of Total Shoulder Arthroplasty, sponsored by University of Minnesota.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 110
- Enrollment target
- 1
- Study location
NCT06143306: Recruiting Phase 4 study of Total Shoulder Arthroplasty, sponsored by University of Minnesota.
NCT06143306 is a Phase 4 study of Total Shoulder Arthroplasty that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 110 participants, above the 58-participant average among 3 other Total Shoulder Arthroplasty trials with a reported enrollment target (90% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06143306, a Phase 4 study of Total Shoulder Arthroplasty, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
The use of ISB in patients undergoing total shoulder arthroplasty (TSA) is the gold standard and results in significantly reduced pain scores and opioid use. However, patients still have pain and the majority require opioids postoperatively as the interscalene block (ISB) doesn't cover all of the dermatomes impacted during TSA. A pectoserratus block typically provides coverage to additional dermatomes that are impacted during TSA. Currently ISB is performed for every patient and perform a pectoserratus block to a portion of our patients undergoing TSA. The purpose of the study is to determine if the addition of the pectoserratus block to the ISB will results in improvement in pain control and decrease in opioid use, among patients undergoing TSA. This is a randomized prospective controlled trial. All patients undergoing total shoulder arthroplasty or reverse total shoulder arthroplasty aged 18-85 will be considered eligible for the study. Participants will be randomized to one of 2 treatment groups. Group 1 will receive an ultrasound guided pectoserratus block with 25 mL of 0.25% bupivacaine. Group 2 will be the control and receive an ultrasound guided pectoserratus block with 25 mL of saline. The drug will be administered by the anesthesiologist in-charge of the participant's care or an anesthesiologist who is a part of the study team.
Primary Outcome
This measurement is the highest pain score within the first 24 hours post-op. Please change abbreviations for time frames to minutes, hours and years respectively. And the Scale is 0 being no pain to 10 being worst pain.
Conditions Studied
Interventions
- DRUG Saline
- DRUG bupivacaine.
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2024-08-14 |
| Est. Completion | 2027-05-01 |
| Phase | Phase 4 |
What NCT06143306 shows while recruiting
NCT06143306 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, above the 58-participant average among 3 other Total Shoulder Arthroplasty trials with a reported enrollment target (90% higher).
The record links to 1 condition, with Total Shoulder Arthroplasty appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.
NCT06143306 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06143306 about?
NCT06143306 is a clinical study titled "Addition of a Pectoserratus Block to Interscalene Block in Patients Undergoing Total Shoulder Replacement". The use of ISB in patients undergoing total shoulder arthroplasty (TSA) is the gold standard and results in significantly reduced pain scores and opioid use. However, patients still have pain and the majority require opioids postoperatively as the interscalene block (ISB) doesn't cover all of the de...
What is the current status of trial NCT06143306?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 110 participants. The study started on 2024-08-14. Estimated completion is 2027-05-01.
What conditions does trial NCT06143306 study?
This clinical trial studies the following conditions: Total Shoulder Arthroplasty.
What interventions are being tested in trial NCT06143306?
The interventions under investigation include: Saline (DRUG), bupivacaine. (DRUG).
Who is sponsoring clinical trial NCT06143306?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06143306 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Total Shoulder Arthroplasty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI